This topic contains a solution. Click here to go to the answer

Author Question: Sovereign Immunity. As part of a plan to stabilize the Republic of Argentina's currency, that ... (Read 34 times)

sc00by25

  • Hero Member
  • *****
  • Posts: 596
Sovereign Immunity. As part of a plan to stabilize the Republic of Argentina's currency, that country and its central bank (collectively, Argentina) issued bonds that provided for repay-ment in U.S. dollars. Repayment would be made in several locations, including New York City. When the bonds began to mature, Argentina lacked sufficient funds to cover them, so it unilat-erally extended the time for payment and offered bondholders substitute instruments as a means of rescheduling the debts. Weltover, Inc, of Panama, plus another Panamanian corpo-ration and a Swiss bank (collectively, Weltover), declined to accept the rescheduling and insist-ed on repayment in New York. When Argentina refused, Weltover brought a breach-of-contract action in a U.S. district court. Argentina moved to dismiss the action, claiming immunity from the jurisdiction of the U.S. courts under the Foreign Sovereign Immunities Act. Weltover con-tended that Argentina's sale of the bonds fell under the commercial activities exception to sovereign immunity. What should the court decide? Discuss fully.

Question 2

If a contractor does not have authority to enter into contracts for the principal then:
 a. he is not an agent b. he is also an agent
  c. he is also an agent if he thinks he has the authority to enter into contracts d. he is still considered an agent in most, but not all, states
  e. none of the other choices are correct



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kingdude89

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

Sovereign immunity
The United States Supreme Court held that the issuance of the Bonds was a commercial ac-tivity under the Foreign Sovereign Immunities Act (FSIA), and the rescheduling of the maturity dates on those instruments was taken in connection with' that activity within the meaning of the FSIA. The Court reasoned that when a foreign government acts, not as a regulator of a market, but in the manner of a private player within that market, its actions are commercial within the meaning of the FSIA. Moreover, because the FSIA provides that the commercial character of an act is to be determined by reference to its nature rather than its purpose, the question is not whether the foreign government is acting with a profit motive or    with the aim of fulfilling uniquely sovereign objectives. Instead, reasoned the Court, the issue is whether the government's particular actions (whatever the motive behind them) are the type of actions by which a private party engages in commerce. The Bonds are in almost all respects garden-variety debt instruments, and, even when they are considered in full context, there is nothing about their issuance that is not analogous to a private commercial transaction. The fact that they were created to help stabilize Argentina's currency is not a valid basis for dis-tinguishing them from ordinary debt instruments, since, under the FSIA, it is irrelevant why Argentina participated in the bond market in the manner of a private actor. It matters only that it did so.

Answer to Question 2

a




sc00by25

  • Member
  • Posts: 596
Reply 2 on: Jun 24, 2018
Thanks for the timely response, appreciate it


AngeliqueG

  • Member
  • Posts: 343
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

Illicit drug use costs the United States approximately $181 billion every year.

Did you know?

The effects of organophosphate poisoning are referred to by using the abbreviations “SLUD” or “SLUDGE,” It stands for: salivation, lacrimation, urination, defecation, GI upset, and emesis.

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library